[카테고리:] 블로그 (Blog)

Whole Exome/Genome Sequencing for autism Whole exome sequencing (WES) and whole genome sequencing (WGS) are state-of-the-art genetic testing methods that have grown in relevance for understanding the genetic underpinnings of Autism Spectrum Disorder (ASD). Autism is a highly heterogeneous disorder with numerous potential genetic contributors. Traditional genetic tests may miss many of these contributors. WES…

Many people have questions about the relationship between autism and developmental disabilities. A developmental disability is a broad term that refers to a long-term condition or impairment that occurs during an individual’s developmental period, usually before birth or during childhood, and affects their physical, intellectual, or behavior functioning. According to a new report from CDC, and now more than…

We’ll explore the differences between Proband WES and Trio WES, case studies showcasing each, and advice on which method may suit you best. Finally, we’ll look at the future of WE. Proband WES The proband is the individual initiating a genetic study of a family. Proband WES is effective for detecting recessive genetic variants and…

Is buccal swab(cheek swab) suitable for collecting DNA samples? In the realm of genetic testing, the method of DNA sample collection is a pivotal determinant of accurate and reliable results. As the curiosity and interest in genetic testing continue to surge, individuals are seeking accessible and comfortable options for DNA sample collection. One such method…

Many customers have asked us at 3billion why the Whole exome sequencing cost is different. Whole exome sequencing (WES) is a sequencing method that targets the protein-coding regions of the genome. Because this requires the analysis of only 1%-2% of the whole genome, WES is more cost-effective than whole genome sequencing. As sequencing technology continues to rapidly…

“Do you know how much it costs to analyze the entire human genome?” This question, which would have been met with astronomical figures a few decades ago, now has a surprisingly affordable answer. The journey of whole genome sequencing (WGS) costs is a fascinating tale of scientific advancement and market dynamics, one that physicians and…

📌 Clinician’s Note: Beyond Aneuploidies: Covering the 60% Single-Gene Risk Gap with Carriership & gNBS. [👉 Read Now: Bridging the 60% Genetic Risk Gap with gNBS] In the rapidly evolving landscape of prenatal care, Non-Invasive Prenatal Testing (NIPT) stands out as a beacon of progress. For expectant parents and healthcare providers alike, understanding the nuances…

The Importance of Reanalyzing Genetic Test Results for Rare Diseases Many companies providing diagnostic genetic testing offer reanalysis services “upon customer request.” But how important is this reanalysis? Let’s explore the significance of reanalysis in diagnostic genetic testing through the five-year reanalysis results conducted by 3billion. Common Questions About Reanalysis “Isn’t genetic testing a one-time…

Whether it is a WES/WGS test for clinical purposes or a DTC test from 23andme or Ancestry that provides ancestry information, a genetic test includes a final results report on what was tested. WES/WGS testing for rare disease diagnosis covers the entire exome or genome and serves the purpose of clinical diagnosis, which in turn…

희귀질환 유전자 검사에서 재분석이 중요한 이유 진단을 위한 유전자 검사를 제공하는 많은 회사가 ‘고객의 요청하에’ 재분석 서비스를 제공하고 있습니다. 그런데, 이 재분석은 얼마나 중요한 걸까요? 3billion에서 진행한 5년 간의 ‘매일 재분석’ 결과를 통해 진단용 유전자 검사에 있어서 ‘재분석의 중요성’에 대해 알아봅시다. “유전자 검사는 한 번만 하면 되는 것 아닌가요?” “왜 재검사가 왜 필요한가요?” “재검사랑 재분석은…